A population based epidemiological study on myasthenia gravis in Estonia

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 74, Issue 12, 2003, Pages 1638-1643

  Oopik M ^a   Kaasik, A E ^b   Jakobsen, J ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b TARTU UNIVERSITY HOSPITAL   (Estonia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BALTIC STATES; CONTROLLED STUDY; DISEASE COURSE; ESTONIA; EUROPE; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MYASTHENIA GRAVIS; NORTH AMERICA; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SEX RATIO; STATISTICS; SURVIVAL;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; EPIDEMIOLOGIC STUDIES; ESTONIA; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; PREVALENCE; SEX DISTRIBUTION;

EID: 0346751963     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.74.12.1638     Document Type: Article

References (30)

1. Hokkanen E. Epidemiology of myasthenia gravis in Finland. J Neurol Sci 1969;9:463-78.
2. Gudmundsson KR. The prevalence of some neurological diseases in Iceland. Acta Neurol Scand 1968;44:57-69.
3. Pirskanen R. Genetic aspects in myasthenia gravis. A familial study of 264 Finnish patients. Acta Neurol Scand 1977;56(6):365-88.
4. Storm-Mathisen A. The epidemiology of myasthenia gravis in Norway. Acta Neurol Scand 1984;70:274-84.
5. Zivadinov R, Jurjevic A, Willheim K, et al. Incidence and prevalence of myasthenia gravis in the county of the coast and Gorski kotar, Croatia, 1976 through 1996. Neuroepidemiology 1998;17:265-72.
6. Lavrnic D, Jarebinski M, Rakocevic-Stojanovic V, et al. Epidemiological and clinical characteristics of myasthenia gravis in Belgrade, Yugoslavia (1983-1992). Acta Neurol Scand 1999;100:168-74.
7. Krivopusk ME. Kliniko-epidemiologicheskie aspekty nasledstvennykh nervnomyshechnykh zabolevanii v Krasnodarskom Krae. Zh Nevropatol Psikhiatr Im S S Korsakova 1991;91:3-5. [In Russian.]
8. Statistical Office of Estonia. Statistical yearbook of Estonia. Tallinn, Estonia: The Office, 1997:42-55.
9. Schoenberg BS. Calculating confidence intervals for rates and ratios. Simplified method utilizing tabular values based on the Poisson distribution. Neuroepidemiology 1983;2:257-65.
10. Waterhouse J, Muir C, Carrea P, et al. eds. Cancer incidence in five continents, vol 3 (IARC Scientific Publications No 15). Lyon: International Agency for research on Cancer, 1976:456.
11. Kurland LT. Descriptive epidemiology of selected neurologic and myopathic disorders with particular reference to a survey in Rochester, Minnesota. J Chron Dis 1958;8:378-418.
12. Oosterhuis HJGH. The natural course of myasthenio gravis: a long-term follow-up study. J Neurol Neurosurg Psychiatry 1989;52:1121-7.
13. Somnier FE, Keiding N, Poulson OB. Epidemiology of myasthenia gravis in Denmark. A longitudinal and comprehensive population survey. Arch Neurology 1991;48:733-9.
14. Christensen PB, Jensen TS, Tsiropulous I, et al. Incidence and prevalence of myosthenia grovis in western Denmark: 1975 to 1989. Neurology 1993;43:1779-83.
15. Yu YL, Hawkins BR, Ip MSM, et al. Myasthenia gravis in Hong Kong Chinese. 1. Epidemiology and adult disease. Acta Neurol Scand 1992;86:113-19.
16. Holtsema H, Mourik J, Rico RE, et al. Myosthenia gravis on the Duch antilles: an epidemiological study. Clin Neurol Neurosurg 2000;102:195-8.
17. Kurtzke JF. Epidemiology of myosthenia gravis. Adv Neurol 1978;19:545-64.
18. Phillips LH, Torner JC, Anderson MS, et al. The epidemiology of myasthenia gravis in central and western Virginia. Neurology 1992;42:1888-93.
19. Schon F, Drayson M, Thompson RA. Myasthenia gravis and elderly people. Age Ageing 1996;25:56-8.
20. Sørensen TT, Holm E-B. Myasthenia gravis in the county of Viborg, Denmark. Eur Neurol 1989;29:177-9.
21. Robertson NP, Deons J, Compston DA. Myasthenia gravis: a population based epidemiological study in Cambridgeshire, England. J Neurol Neurosurg Psychiatry 1998;65:492-6.
22. Kyriallis K, Hristova AH, Middleton LT. What is the real epidemiology of myasthenia gravis? [Abstract.] Neurology 1995;45(suppl 4):A351-2.
23. Emilia-Romagna Study Group. Incidence of myasthenia gravis in the Emilia-Romagna region: a prospective study. Neurology 1998;51:255-8.
24. Phillips LH, Torner JC. Epidemiologic evidence for a changing natural history of myasthenia gravis. Neurology 1996;47:1233-8.
25. Thorlacius S, Aarli JA, Riise T, et al. Associated disorders in myasthenia gravis: autoimmune diseases and their relation to thymectomy. Acta Neurol Scand 1989;80:290-5.
26. Aarli JA. Late-onset myasthenia gravis: a changing scene. Arch Neurol 1999;56:25-7.
27. D'Alessandro R, Granieri E, Benassi G, et al. Comparative study on the prevalence of myasthenia gravis in the provinces of Bologna and Ferrara, Italy. Acta Neurol Scand 1991;83:83-8.
28. Beekman R, Kuks JB, Oosterhuis HJ. Myasthenia gravis: diagnosis and follow-up of 100 consecutive patients. J Neurol 1997;244:112-18.
29. Donaldson DH, Ansher M, Horan S, et al. The relationship of age to outcome in myasthenia gravis. Neurology 1990;40:786-90.
30. Christensen PB, Jensen TS, Tsiropoulos I, et al. Associated autoimmune diseases in myasthenia gravis. Acta Neurol Scand 1995;91:192-5.